Search

Your search keyword '"Lophatananon, A"' showing total 1,270 results

Search Constraints

Start Over You searched for: Author "Lophatananon, A" Remove constraint Author: "Lophatananon, A"
1,270 results on '"Lophatananon, A"'

Search Results

53. The association between weight at birth and breast cancer risk revisited using Mendelian randomisation

54. European polygenic risk score for prediction of breast cancer shows similar performance in Asian women

55. Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants

56. Investigation of the association between the antibody responses to neurotropic viruses and dementia outcomes in the UK Biobank

57. Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk.

58. Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression

59. Fine-Scale Mapping of the 5q11.2 Breast Cancer Locus Reveals at Least Three Independent Risk Variants Regulating MAP3K1

60. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk.

61. Shingles, Zostavax vaccination and risk of developing dementia: a nested case–control study—results from the UK Biobank cohort

62. Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset

63. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.

64. FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.

65. Re-evaluating genetic variants identified in candidate gene studies of breast cancer risk using data from nearly 280,000 women of Asian and European ancestryResearch in context

66. Evaluation of a questionnaire to assess nutritional knowledge, attitudes and practices in a Thai population

68. Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.

69. Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers

70. Genome-wide association studies identify four ER negative-specific breast cancer risk loci.

71. 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

72. Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)

73. Prediction models for prostate cancer to be used in the primary care setting: a systematic review

74. Relationship of self-reported body size and shape with risk for prostate cancer: A UK case-control study.

75. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

76. The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

77. Responses to provision of personalised cancer risk information: a qualitative interview study with members of the public

80. European polygenic risk score for prediction of breast cancer shows similar performance in Asian women

81. Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants

82. Development and evaluation of polygenic risk scores for prediction of endometrial cancer risk in European women

83. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

84. Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study

85. Quantifying the Effect of Physical Activity on Endometrial Cancer Risk

88. Supplementary Tables and References from BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

89. Supplementary Table 1 from Fine-Scale Mapping of the 4q24 Locus Identifies Two Independent Loci Associated with Breast Cancer Risk

90. Data from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

91. Supplementary Table 3 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

92. Supplementary Table 2 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

93. Supplementary Table Legend from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

94. Supplementary Table 1 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

95. Data from BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

96. Supplementary Figures from BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

97. Data from 19p13.1 Is a Triple-Negative–Specific Breast Cancer Susceptibility Locus

98. Supplementary Tables 1-13 from 19p13.1 Is a Triple-Negative–Specific Breast Cancer Susceptibility Locus

99. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

100. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.

Catalog

Books, media, physical & digital resources